JPRN-UMIN000045687已完成未知
DatabasE Study For patIeNts trEated with GLP-1RA in Japan - DEFINE-G
ational Center for Global Health and Medicine0 个研究点目标入组 3,800 人开始时间: 2021年10月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 3,800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Primary Outcome 1. Those with type 1 diabetes mellitus. 2. Those with history of gestational diabetes between 360 days before the index date and 360 days after the index date
研究者
相似试验
进行中（未招募）
不适用
Effects of once-daily administered GLP-1 Receptoragonist Lixisenatide in combination with basal Insulin on glycemic control in patients with type-2 diabetes mellitus not achieving therapeutic targets with premixed insulin strategy10 patients (both gender) under treatment with premixed insulin (2-3 injections) and HbA1c>7% will be switched to basal insulin glargine (Lantus, once daily) and GLP-1 receptor agonist Lixisenatide (Lyxumia, once daily).EUCTR2013-005334-37-ATMedical University of Vienna / Medizinische Universität Wien
已完成
不适用
DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R AgonistsDiabetesNCT01575301University of Dundee411
已完成
不适用
Study of the clinical effect of GLP-1 analogue for body weight, body fat, insulin secretion in patients with type 2 diabetesJPRN-UMIN000009638Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine130
招募中
不适用
Observation of using GLP-1 receptor agonist for wellness of brain activity in type 2 diabetes patients with mild cognitive impairmentJPRN-UMIN000030840Ogawa Red Cross Hospital50
招募中
4 期
The effect of a GLP-1 agonist in patients with a dual diagnosis of Parkinson's Disease and Type 2 Diabetes MellitusType 2 Diabetes MellitusParkinson's DiseaseACTRN12620000627954St Vincent's Health Network12